Cases & Deals

Share

Celgene collaborates with GlobeImmune

May 2009

Clients Celgene International, Inc.

Jones Day advised Celgene International, Inc., a multinational biopharmaceutical company, in connection with its worldwide strategic collaboration with and related equity investment in GlobeImmune, Inc., a company focused on the discovery, development and commercialization of multiple product candidates based on targeted molecular immunotherapy for the treatment of cancer.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.